Joe Hancock, the owner of a family plumbing and heating business in Frankfort, Ky., immediately thought it was a bad sign ...
During July and August 2025, approximately 1 in 10 U.S. adults reported taking a GLP-1 medication during the previous year ...
A psychedelic drug from Helus Pharma improved depression in a study, but is facing safety questions with a number of serious ...
It doesn’t have quite the same ring to it as “Medicare for All.” But House Dems have coalesced around a policy priority to ...
Apple and OpenEvidence are launching a study based around an experimental AI-powered health chat app, hinting at possible new ...
The FDA has rejected ivonescimab, a treatment for a type of lung cancer developed by U.S. biotech Summit Therapeutics and the ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
Enforcement of the Trump administration's stringent new Medicaid work requirements have delayed for six months, until July 1, ...
Senator-elect Abdul El-Sayed talks to STAT about restoring trust in science, the state of public health, and RFK Jr.
As researchers struggle to understand phone addiction, young people are finding ways to reclaim their attention and push back ...
The Boston Globe investigates if Boston Scientific's marketing of its cardiac implant, Watchman, outpaced the science.